Gregory D Ayers Selected Research

Gregory D Ayers Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 12/2002
11	Melanoma (Melanoma, Malignant) 01/2022 - 01/2010
10	Breast Neoplasms (Breast Cancer) 05/2021 - 03/2006
5	Neoplasm Metastasis (Metastasis) 10/2018 - 03/2006
4	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 12/2002
3	Colonic Neoplasms (Colon Cancer) 01/2017 - 02/2004
2	Adenocarcinoma 01/2022 - 09/2014
2	Sarcoidosis (Schaumann Disease) 01/2021 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 01/2018
2	Pain (Aches) 05/2019 - 06/2006
2	Hepatoblastoma 06/2013 - 12/2012
2	Vomiting 12/2010 - 03/2009
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 06/2010 - 06/2004
2	Polyps 06/2010 - 06/2004
2	Hand-Foot Syndrome 06/2006 - 12/2002
1	Back Pain (Backache) 01/2021
1	Pulmonary Sarcoidosis 01/2021
1	Shoulder Pain 07/2020
1	Rotator Cuff Injuries 05/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018
1	Rectal Neoplasms (Rectal Cancer) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Polyploidy 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 02/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 06/2015
1	Extranodal Extension 09/2014
1	Virus Diseases (Viral Diseases) 07/2014

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2004
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 03/2014
4	Immune Checkpoint InhibitorsIBA 05/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 06/2004
4	Celecoxib (Celebrex)FDA Link 06/2010 - 12/2002
3	Chemokine ReceptorsIBA 01/2021 - 03/2014
3	NF-kappa B (NF-kB)IBA 09/2012 - 01/2010
2	ChemokinesIBA 06/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2021 - 01/2010
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2019
2	LigandsIBA 01/2018 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 01/2013
2	Pharmaceutical PreparationsIBA 10/2017 - 06/2010
2	Phosphotransferases (Kinase)IBA 10/2017 - 12/2014
2	Aurora Kinase AIBA 06/2016 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 12/2014 - 07/2010
2	Messenger RNA (mRNA)IBA 12/2012 - 02/2004
2	Capecitabine (Xeloda)FDA Link 06/2006 - 12/2002
1	avelumabIBA 01/2022
1	AlpelisibIBA 05/2021
1	copanlisibIBA 05/2021
1	gedatolisibIBA 05/2021
1	Opiate AlkaloidsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	trametinibIBA 01/2021
1	Levofloxacin (Levaquin)FDA Link 01/2021
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2021
1	Anti-Idiotypic AntibodiesIBA 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	dabrafenibIBA 01/2021
1	Rifabutin (Ansamycin)FDA Link 01/2021
1	CholesterolIBA 11/2020
1	PhosphoproteinsIBA 01/2020
1	Cyclin D1IBA 01/2019
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019
1	venetoclaxIBA 12/2018
1	Peptides (Polypeptides)IBA 10/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	STA 9090IBA 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2017
1	Granzymes (Granzyme)IBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	NVP-BKM120IBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	RNA (Ribonucleic Acid)IBA 06/2016
1	Valganciclovir FDA Link 02/2016
1	Bevacizumab (Avastin)FDA Link 02/2016
1	IpilimumabIBA 03/2015
1	Interleukin-2 (IL2)IBA 03/2015
1	B7-H1 AntigenIBA 03/2015
1	Aurora KinasesIBA 01/2015
1	Histocompatibility Antigens Class IIIBA 12/2014
1	Chemokine CCL11IBA 12/2014
1	Protein Isoforms (Isoforms)IBA 07/2014
1	Zinc Finger E-box-Binding Homeobox 1IBA 05/2014
1	Indicators and Reagents (Reagents)IBA 04/2014

Therapy/Procedure

19	Therapeutics 01/2022 - 04/2006
4	Neoadjuvant Therapy 09/2014 - 06/2013
3	Drug Therapy (Chemotherapy) 01/2018 - 12/2002
2	Immunotherapy 01/2021 - 06/2016
1	Aftercare (After-Treatment) 07/2020
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2019
1	Minimally Invasive Surgical Procedures 01/2018
1	Combined Modality Therapy 01/2018
1	Operative Surgical Procedures 06/2015